After Denosumab Deals, Alvotech Lines Up Filings
Firm Reports Positive Trial Data For AVT03 Biosimilar To Prolia/Xgeva Ahead Of Submissions
• By David Wallace
Alvotech is preparing multiple denosumab filings in “major global markets” • Source: Shutterstock 
